Laura Cebrián
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 12
- Pharmacology 11
- Antibiotics Pharmacokinetics and Efficacy 11
- Co-authors
- Gloria Royo (12 shared papers)Juan Carlos Rodrı́guez (12 shared papers)Félix Gutiérrez (1 shared paper)Carlos Mirete (1 shared paper)A. Hidalgo (1 shared paper)Mar Masiá (1 shared paper)Isabel Escribano (10 shared papers)J. M. Sharp (1 shared paper)
- Journals
- International Journal of Antimicrobial Agents (4 papers)Apmis (3 papers)Chemotherapy (2 papers)Clinical Infectious Diseases (1 paper)Veterinary Record (1 paper)
- Partner nations
- Spain
In The Last Decade
Laura Cebrián
25 papers receiving 350 citations
Peers
Comparison fields: 5 of 61
- Molecular Medicine 84
- Applied Microbiology and Biotechnology 19
- Microbiology 58
- Microbiology 7
- Epidemiology 230
Countries citing papers authored by Laura Cebrián
This map shows the geographic impact of Laura Cebrián's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Cebrián with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Cebrián more than expected).
Fields of papers citing papers by Laura Cebrián
This network shows the impact of papers produced by Laura Cebrián. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Cebrián. The network helps show where Laura Cebrián may publish in the future.
Co-authors
The 25 scholars most cited alongside Laura Cebrián, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 184 | |
| 2 | 1993 | 29 | |
| 3 | 2003 | 22 | |
| 4 | 2004 | 17 | |
| 5 | 2005 | 16 | |
| 6 | 2021 | 14 | |
| 7 | 2005 | 11 | |
| 8 | 2003 | 10 | |
| 9 | 2005 | 9 | |
| 10 | beta-lactam susceptibility of Escherichia coli isolates from urinary tract infections exhibiting different resistance phenotypes. | 2008 | 9 |
| 11 | 2018 | 7 | |
| 12 | 2005 | 7 | |
| 13 | 2006 | 5 | |
| 14 | 2017 | 5 | |
| 15 | 2008 | 4 | |
| 16 | 2006 | 4 | |
| 17 | Actividad de cefpodoxima y otros betalactámicos orales frente a Haemophilus influenzae y Streptococcus pneumoniae con distinta sensibilidad a la penicilina | 2006 | 3 |
| 18 | 2005 | 3 | |
| 19 | 2006 | 3 | |
| 20 | 2006 | 2 |
About Laura Cebrián
Laura Cebrián is a scholar working on Molecular Medicine, Pharmacology, Epidemiology, Microbiology and Food Science, having authored 26 papers that have together received 370 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers), Salmonella and Campylobacter epidemiology (5 papers), Pneumonia and Respiratory Infections (4 papers), Pharmaceutical and Antibiotic Environmental Impacts (3 papers), Bacterial Infections and Vaccines (3 papers), Tuberculosis Research and Epidemiology (2 papers) and Escherichia coli research studies (2 papers). The work is most often cited by research in Molecular Medicine (84 citations), Applied Microbiology and Biotechnology (19 citations), Microbiology (58 citations), Microbiology (7 citations) and Epidemiology (230 citations). Laura Cebrián has collaborated with scholars based in Spain. Frequent co-authors include Gloria Royo, Juan Carlos Rodrı́guez, Félix Gutiérrez, Carlos Mirete, A. Hidalgo, Mar Masiá, Isabel Escribano, J. M. Sharp, M. De las Heras and Lluís Ferrer. Their work appears in journals such as International Journal of Antimicrobial Agents, Apmis, Chemotherapy, Clinical Infectious Diseases and Veterinary Record.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.